Cite
HARVARD Citation
Klamová, H. et al. (n.d.). Evaluation of 5‐year imatinib treatment of 458 patients with CP‐CML in routine clinical practice and prognostic impact of different BCR‐ABL cutoff levels. Cancer medicine. pp. 216-225. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Klamová, H. et al. (n.d.). Evaluation of 5‐year imatinib treatment of 458 patients with CP‐CML in routine clinical practice and prognostic impact of different BCR‐ABL cutoff levels. Cancer medicine. pp. 216-225. [Online].